Skip to main content
Top
Published in: Neurology and Therapy 1/2019

Open Access 01-06-2019 | Multiple Sclerosis | Brief Report

PatientConcept App: Key Characteristics, Implementation, and its Potential Benefit

Authors: Michael Lang, Martin Mayr, Stefan Ringbauer, Lukas Cepek

Published in: Neurology and Therapy | Issue 1/2019

Login to get access

Abstract

Introduction

In addition to a wide range of disease-related burdens, patients with multiple sclerosis (MS) are challenged by long-term medication and complex disease management plans, often leading to decreased adherence. Earlier studies have indicated that patient support through intensified communication can positively impact adherence. During recent years, the use of mobile health applications has gained importance in patient communication and disease management.

Objective

Our objective was to describe a novel software application providing innovative features that engage patient–physician contact and to evaluate users’ acceptance.

Methods

A novel software application ensuring data security was developed. Various innovative modules have been implemented, enabling bidirectional communication between treating physicians and patients, supporting therapy monitoring and management, and allowing the collection of large sets of anonymous patient data. The currently conducted FASTER study will analyze the acceptance of patients and physicians using this novel application.

Results

PatientConcept is a free app available for download since 2016. Meanwhile, it has been successfully implemented. First preliminary results indicate high acceptance among users. The clinical benefit will have to be tested in larger patient populations.

Conclusion

This ID-associated application may provide a secure, feasible, and cost-optimized possibility to intensify and simplify the communication between patients and their treating physicians, thus promising an exceptional benefit to both.
Literature
1.
go back to reference Menzin J, Caon C, Nichols C, White LA, Friedman M, Pill MW. Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis. J Manag Care Pharm. 2013;19:S24–40.PubMed Menzin J, Caon C, Nichols C, White LA, Friedman M, Pill MW. Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis. J Manag Care Pharm. 2013;19:S24–40.PubMed
2.
go back to reference Gerber B, Cowling T, Chen G, Yeung M, Duquette P, Haddad P. The impact of treatment adherence on clinical and economic outcomes in multiple sclerosis: real world evidence from Alberta, Canada. Mult Scler Relat Disord. 2017;18:218–24.CrossRef Gerber B, Cowling T, Chen G, Yeung M, Duquette P, Haddad P. The impact of treatment adherence on clinical and economic outcomes in multiple sclerosis: real world evidence from Alberta, Canada. Mult Scler Relat Disord. 2017;18:218–24.CrossRef
3.
go back to reference Lugaresi A, Rottoli MR, Patti F. Fostering adherence to injectable disease-modifying therapies in multiple sclerosis. Expert Rev Neurother. 2014;14:1029–42.CrossRef Lugaresi A, Rottoli MR, Patti F. Fostering adherence to injectable disease-modifying therapies in multiple sclerosis. Expert Rev Neurother. 2014;14:1029–42.CrossRef
4.
go back to reference Remington G, Rodriguez Y, Logan D, Williamson C, Treadaway K. Facilitating medication adherence in patients with multiple sclerosis. Int J MS Care. 2013;15:36–45.CrossRef Remington G, Rodriguez Y, Logan D, Williamson C, Treadaway K. Facilitating medication adherence in patients with multiple sclerosis. Int J MS Care. 2013;15:36–45.CrossRef
5.
go back to reference Steinberg SC, Faris RJ, Chang CF, Chan A, Tankersley MA. Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study. Clin Drug Investig. 2010;30:89–100.CrossRef Steinberg SC, Faris RJ, Chang CF, Chan A, Tankersley MA. Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study. Clin Drug Investig. 2010;30:89–100.CrossRef
6.
go back to reference Devonshire V, Lapierre Y, Macdonell R, et al. The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis. Eur J Neurol. 2011;18:69–77.CrossRef Devonshire V, Lapierre Y, Macdonell R, et al. The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis. Eur J Neurol. 2011;18:69–77.CrossRef
7.
go back to reference Treadaway K, Cutter G, Salter A, et al. Factors that influence adherence with disease-modifying therapy in MS. J Neurol. 2009;256:568–76.CrossRef Treadaway K, Cutter G, Salter A, et al. Factors that influence adherence with disease-modifying therapy in MS. J Neurol. 2009;256:568–76.CrossRef
8.
go back to reference Birnbaum F, Lewis D, Rosen RK, Ranney ML. Patient engagement and the design of digital health. Acad Emerg Med. 2015;22:754–6.CrossRef Birnbaum F, Lewis D, Rosen RK, Ranney ML. Patient engagement and the design of digital health. Acad Emerg Med. 2015;22:754–6.CrossRef
9.
go back to reference Payne HE, Lister C, West JH, Bernhardt JM. Behavioral functionality of mobile apps in health interventions: a systematic review of the literature. JMIR Mhealth Uhealth. 2015;3:e20.CrossRef Payne HE, Lister C, West JH, Bernhardt JM. Behavioral functionality of mobile apps in health interventions: a systematic review of the literature. JMIR Mhealth Uhealth. 2015;3:e20.CrossRef
10.
go back to reference Haase R, Schultheiss T, Kempcke R, Thomas K, Ziemssen T. Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study. J Med Internet Res. 2012;14:e135.CrossRef Haase R, Schultheiss T, Kempcke R, Thomas K, Ziemssen T. Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study. J Med Internet Res. 2012;14:e135.CrossRef
11.
go back to reference Kornhuber A, Lang M. Interne und externe Einflussfaktoren auf die Adhärenz bei Multipler Sklerose—eine retrospektive und prospektive Analyse mit der Medication Possession Ratio. In: 87 Kongress der Deutschen Gesellschaft für Neurologie 2014. Kornhuber A, Lang M. Interne und externe Einflussfaktoren auf die Adhärenz bei Multipler Sklerose—eine retrospektive und prospektive Analyse mit der Medication Possession Ratio. In: 87 Kongress der Deutschen Gesellschaft für Neurologie 2014.
12.
go back to reference Anglada-Martinez H, Riu-Viladoms G, Martin-Conde M, Rovira-Illamola M, Sotoca-Momblona JM, Codina-Jane C. Does mHealth increase adherence to medication? Results of a systematic review. Int J Clin Pract. 2015;69:9–32.CrossRef Anglada-Martinez H, Riu-Viladoms G, Martin-Conde M, Rovira-Illamola M, Sotoca-Momblona JM, Codina-Jane C. Does mHealth increase adherence to medication? Results of a systematic review. Int J Clin Pract. 2015;69:9–32.CrossRef
13.
go back to reference Rasova K, Martinkova P, Pavlikoma M, et al. Physical therapy provision in multiple sclerosis across Europe: a regional lottery? Eur J Phys Rehabil Med. 2015;51:850–2.PubMed Rasova K, Martinkova P, Pavlikoma M, et al. Physical therapy provision in multiple sclerosis across Europe: a regional lottery? Eur J Phys Rehabil Med. 2015;51:850–2.PubMed
Metadata
Title
PatientConcept App: Key Characteristics, Implementation, and its Potential Benefit
Authors
Michael Lang
Martin Mayr
Stefan Ringbauer
Lukas Cepek
Publication date
01-06-2019
Publisher
Springer Healthcare
Published in
Neurology and Therapy / Issue 1/2019
Print ISSN: 2193-8253
Electronic ISSN: 2193-6536
DOI
https://doi.org/10.1007/s40120-019-0133-4

Other articles of this Issue 1/2019

Neurology and Therapy 1/2019 Go to the issue